Anavex Life Sciences Announces the Appointment of Walter E Kaufmann, MD as Chief Medical Officer
NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]
Natus Medical to Hold 2018 Fourth Quarter Financial Results Conference Call on February 13th
PLEASANTON, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ: BABY) today announced that the Company will release […]
Nova LifeStyle, Inc. Takes Action to Reinstate Investor Confidence Damaged By Malicious Research Report and Discloses Initiation of Class Action Litigation Precipitated by that Malicious Research Report
LOS ANGELES, Jan. 02, 2019 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) today responded to a document published by […]
Arcturus Therapeutics to Develop ARCT-810 for Treatment of Ornithine Transcarbamylase (OTC) Deficiency
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on […]
ConnectOne Bancorp, Inc. Completes Merger With Greater Hudson Bank
ENGLEWOOD CLIFFS, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company […]
Sunesis Pharmaceuticals Announces Advancement into 100mg Cohort of Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies
– 50 mg Cohort Completed – – Clinical Update Expected in the Second Quarter of 2019 – SOUTH SAN FRANCISCO, […]
Cara Therapeutics Announces No Modifications in Trial Size After Completion of Interim Statistical Assessment For KALM-1 Phase 3 Trial Of KORSUVA™ Injection in Hemodialysis Patients with Pruritus
– Trial continues as planned with enrollment target of 350 patients – – Top-line data readout expected in the first […]
Tonix Pharmaceuticals to Present at Upcoming Investor Conferences and Participate in Featured Panel Discussion
NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today […]
ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2
LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing […]
Karyopharm to Present at the 37th Annual J.P. Morgan Healthcare Conference
NEWTON, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Michael […]
